This deal follows Springer Nature's summertime acquisition of protocols.io, a US platform for developing and sharing reproducible methods securely.
Since working together since 2015 the partnership created AI tools to speed up and improve the publishing process. Those tools identify appropriate editors to guide a manuscript through the submission process, increasing reviewer acceptance rates by recommending the best people to peer review a manuscript, and automating the identification of potential problems with papers, such as plagiarism to safeguard authenticity.
“After years of successful collaboration I am excited to see how we can scale and accelerate the further improvements we believe AI can help us deliver throughout the research process for our authors and customers,” says Matthias Wissel, Chief Information Officer at Springer Nature.
Slimmer AI said with the sale of its science division it would now continue to focus exclusively on its venture studio activities where it works 'with founders to build amazing new AI-first products and ventures'.
"It has been an honour to co-build transformative AI products together with Springer Nature over the past few years, and we've shared many successes and learnings," says Heather Devereaux, Managing Director of Slimmer AI Science.
Lead image: via Unsplash. Photo: CHUTTERSNAP